Cargando…

Statistical methods for analyzing immunosignatures

BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Justin R, Stafford, Phillip, Johnston, Stephen A, Dinu, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175483/
https://www.ncbi.nlm.nih.gov/pubmed/21854615
http://dx.doi.org/10.1186/1471-2105-12-349
_version_ 1782212161974566912
author Brown, Justin R
Stafford, Phillip
Johnston, Stephen A
Dinu, Valentin
author_facet Brown, Justin R
Stafford, Phillip
Johnston, Stephen A
Dinu, Valentin
author_sort Brown, Justin R
collection PubMed
description BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications. METHODS: We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling. RESULTS: We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery. CONCLUSION: Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery.
format Online
Article
Text
id pubmed-3175483
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31754832011-09-21 Statistical methods for analyzing immunosignatures Brown, Justin R Stafford, Phillip Johnston, Stephen A Dinu, Valentin BMC Bioinformatics Methodology Article BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications. METHODS: We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling. RESULTS: We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery. CONCLUSION: Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery. BioMed Central 2011-08-19 /pmc/articles/PMC3175483/ /pubmed/21854615 http://dx.doi.org/10.1186/1471-2105-12-349 Text en Copyright ©2011 Brown et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Brown, Justin R
Stafford, Phillip
Johnston, Stephen A
Dinu, Valentin
Statistical methods for analyzing immunosignatures
title Statistical methods for analyzing immunosignatures
title_full Statistical methods for analyzing immunosignatures
title_fullStr Statistical methods for analyzing immunosignatures
title_full_unstemmed Statistical methods for analyzing immunosignatures
title_short Statistical methods for analyzing immunosignatures
title_sort statistical methods for analyzing immunosignatures
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175483/
https://www.ncbi.nlm.nih.gov/pubmed/21854615
http://dx.doi.org/10.1186/1471-2105-12-349
work_keys_str_mv AT brownjustinr statisticalmethodsforanalyzingimmunosignatures
AT staffordphillip statisticalmethodsforanalyzingimmunosignatures
AT johnstonstephena statisticalmethodsforanalyzingimmunosignatures
AT dinuvalentin statisticalmethodsforanalyzingimmunosignatures